- Advertisement -
- Advertisement -
- Advertisement -

Noam Galai
- Since October, the US FDA has been running a trial of a program that aims to have more frequent communication with pharma companies that have drug applications pending with the agency to ease the process.
- FDA Commissioner Marty Makary said






